China Historical Cash Flow
| 600511 Stock | 32.56 0.18 0.55% |
Analysis of China National cash flow over time is an excellent tool to project China National Medicines future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Net Income of 2.6 B or Other Cashflows From Financing Activities of 249.2 M as it is a great indicator of China National ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining China National Medicines latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether China National Medicines is a good buy for the upcoming year.
China |
About China Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in China balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which China's non-liquid assets can be easily converted into cash.
China National Cash Flow Chart
Add Fundamental
Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in China National Medicines financial statement analysis. It represents the amount of money remaining after all of China National Medicines operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Most accounts from China National's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into China National Medicines current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China National Medicines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At present, China National's Capital Expenditures is projected to increase significantly based on the last few years of reporting. The current year's Net Income is expected to grow to about 2.6 B, whereas Total Cash From Financing Activities is projected to grow to (637.8 M).
China National cash flow statement Correlations
Click cells to compare fundamentals
China National Account Relationship Matchups
High Positive Relationship
High Negative Relationship
China National cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Capital Expenditures | 69.1M | 95.1M | 129.8M | 145.1M | 166.9M | 175.2M | |
| Net Income | 1.4B | 1.8B | 2.0B | 2.1B | 2.5B | 2.6B | |
| Other Cashflows From Financing Activities | (47.0M) | (180.4M) | 35.5M | 263.7M | 237.3M | 249.2M | |
| Dividends Paid | 613.1M | 637.8M | 612.0M | 709.6M | 816.0M | 856.8M | |
| Total Cash From Operating Activities | 1.3B | 2.0B | 2.4B | 2.7B | 3.1B | 3.3B | |
| Total Cash From Financing Activities | (1.1B) | (1.2B) | (730.6M) | (746.0M) | (671.4M) | (637.8M) | |
| Change To Inventory | 300.4M | (475.5M) | (207.6M) | (243.6M) | (219.2M) | (208.3M) | |
| Change To Account Receivables | (747.5M) | (1.6B) | (107.1M) | (714.2M) | (642.8M) | (674.9M) | |
| Total Cashflows From Investing Activities | (194.6M) | 14.7M | (56.5M) | (123.0M) | (110.7M) | (105.2M) | |
| Other Cashflows From Investing Activities | 6.6M | 132.2M | 7.2M | 2.9M | 2.6M | 2.4M | |
| Investments | 2.9M | (15.8M) | (152.3M) | (129.3M) | (116.4M) | (110.6M) | |
| Change In Cash | 514.6M | 1.1B | 1.6B | 2.0B | 2.3B | 2.4B | |
| Net Borrowings | (711.9M) | 62.9M | (143.7M) | (291.3M) | (335.0M) | (351.8M) | |
| Depreciation | 172.6M | 178.8M | 189.6M | 200.0M | 230.0M | 138.0M | |
| Change To Netincome | 84.6M | 211.8M | (40.4M) | (16.9M) | (15.3M) | (14.5M) | |
| End Period Cash Flow | 6.1B | 7.2B | 8.8B | 10.8B | 12.4B | 7.1B | |
| Free Cash Flow | 1.2B | 1.9B | 2.3B | 2.6B | 3.0B | 1.8B | |
| Change In Working Capital | (218.1M) | 34.6M | 304.7M | 504.8M | 580.5M | 609.5M | |
| Begin Period Cash Flow | 5.6B | 6.1B | 7.2B | 8.8B | 10.2B | 6.4B | |
| Other Non Cash Items | 41.2M | 47.9M | 36.4M | 48.4M | 43.6M | 64.6M |
Currently Active Assets on Macroaxis
Other Information on Investing in China Stock
The Cash Flow Statement is a financial statement that shows how changes in China balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which China's non-liquid assets can be easily converted into cash.